Literature DB >> 31511234

hs-CRP Is Associated With Incident Diabetic Nephropathy: Findings From the Jackson Heart Study.

Satyesh K Sinha1,2, Susanne B Nicholas3, Jung Hye Sung4, Adolfo Correa5, Tripathi B Rajavashisth6,2,7, Keith C Norris2, Jae Eun Lee4.   

Abstract

OBJECTIVE: African Americans (AA) suffer disproportionately from diabetic nephropathy (DN). C-reactive protein (CRP) has been associated with prevalent DN, but its association with incident DN in AA is unknown. We examined hs-CRP and incident DN in AA. RESEARCH DESIGN AND METHODS: We conducted a longitudinal analysis of data from exams 1, 2, and 3 in 4,043 eligible Jackson Heart Study (JHS) participants. Participants with DN or without hs-CRP at exam 1 were excluded. Incident DN was defined as urinary albumin-to-creatinine ratio (ACR) >30 mg/g or self-reported dialysis/transplantation and type 2 diabetes mellitus (DM) or HbA1c >6.5% by exam 2 or 3 among participants free of DN at exam 1. Kaplan-Meier curves examined DN event-free survival probability by hs-CRP. With Cox proportional hazards regression we estimated hazard ratios (HRs) and 95% CI for DN by hs-CRP tertiles, adjusting for demographics and clinical and laboratory data.
RESULTS: During 7.8 years of median follow-up time, participants who developed DN had significantly higher baseline hs-CRP, age, fasting glucose, triglycerides, ACR, systolic blood pressure, waist circumference, and duration of DM (P < 0.05). The overall incident rate of DN was 7.9%. The mean time to incident DN was shorter for participants with hs-CRP in the high tertile (>4.24 mg/L) than in the low tertile (<1.46 mg/L); P < 0.001. Participants with high hs-CRP had higher incidence of DN (HR 2.34, 95% CI 1.04-5.24) versus the reference group.
CONCLUSIONS: Inflammation, as measured by hs-CRP levels, may be associated with incident DN in AA. Further studies are warranted to replicate and elucidate the basis for this association.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31511234      PMCID: PMC6804609          DOI: 10.2337/dc18-2563

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   17.152


  39 in total

Review 1.  Role of macrophages in the pathogenesis of diabetic nephropathy.

Authors:  K Shikata; H Makino
Journal:  Contrib Nephrol       Date:  2001       Impact factor: 1.580

2.  Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors.

Authors:  Michelle E Tarver-Carr; Neil R Powe; Mark S Eberhardt; Thomas A LaVeist; Raynard S Kington; Josef Coresh; Frederick L Brancati
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

Review 3.  Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease.

Authors:  Kimberly Harding; Tesfaye B Mersha; Fern A Webb; Joseph A Vassalotti; Susanne B Nicholas
Journal:  Am J Nephrol       Date:  2017-08-05       Impact factor: 3.754

4.  Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.

Authors:  Subodh Verma; Shu-Hong Li; Mitesh V Badiwala; Richard D Weisel; Paul W M Fedak; Ren-Ke Li; Bikramjit Dhillon; Donald A G Mickle
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

5.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

Authors:  Toshiharu Ninomiya; Vlado Perkovic; Bastiaan E de Galan; Sophia Zoungas; Avinesh Pillai; Meg Jardine; Anushka Patel; Alan Cass; Bruce Neal; Neil Poulter; Carl-Erik Mogensen; Mark Cooper; Michel Marre; Bryan Williams; Pavel Hamet; Giuseppe Mancia; Mark Woodward; Stephen Macmahon; John Chalmers
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

6.  Serum high-sensitivity C-reactive protein levels are associated with high risk of development, not progression, of diabetic nephropathy among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT7]).

Authors:  Yasuaki Hayashino; Tsuyoshi Mashitani; Satoru Tsujii; Hitoshi Ishii
Journal:  Diabetes Care       Date:  2014-08-28       Impact factor: 19.112

7.  Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up.

Authors:  Chaochen Wang; Hiroshi Yatsuya; Koji Tamakoshi; Mayu Uemura; Yuanying Li; Keiko Wada; Kentaro Yamashita; Leo Kawaguchi; Hideaki Toyoshima; Atsuko Aoyama
Journal:  Diabetes Metab Res Rev       Date:  2013-07       Impact factor: 4.876

8.  C-reactive protein induces M-CSF release and macrophage proliferation.

Authors:  Sridevi Devaraj; Jung-Mi Yun; Catherine Duncan-Staley; Ishwarlal Jialal
Journal:  J Leukoc Biol       Date:  2008-11-13       Impact factor: 4.962

9.  The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.

Authors:  Ervin R Fox; Emelia J Benjamin; Daniel F Sarpong; Harsha Nagarajarao; Jason K Taylor; Michael W Steffes; Abdullah K Salahudeen; Michael F Flessner; Ermeg L Akylbekova; Caroline S Fox; Robert J Garrison; Herman A Taylor
Journal:  BMC Nephrol       Date:  2010-01-15       Impact factor: 2.388

10.  Diabetic kidney disease: a report from an ADA Consensus Conference.

Authors:  Katherine R Tuttle; George L Bakris; Rudolf W Bilous; Jane L Chiang; Ian H de Boer; Jordi Goldstein-Fuchs; Irl B Hirsch; Kamyar Kalantar-Zadeh; Andrew S Narva; Sankar D Navaneethan; Joshua J Neumiller; Uptal D Patel; Robert E Ratner; Adam T Whaley-Connell; Mark E Molitch
Journal:  Diabetes Care       Date:  2014-10       Impact factor: 19.112

View more
  10 in total

Review 1.  Etiopathogenesis of kidney disease in minority populations and an updated special focus on treatment in diabetes and hypertension.

Authors:  Ebele M Umeukeje; Jasmine T Washington; Susanne B Nicholas
Journal:  J Natl Med Assoc       Date:  2022-05-17       Impact factor: 2.739

2.  Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin.

Authors:  Antonio Ceriello; Francesco Prattichizzo; Rosalba La Grotta; Paola de Candia; Fabiola Olivieri; Giulia Matacchione; Angelica Giuliani; Maria Rita Rippo; Elena Tagliabue; Monica Mancino; Francesca Rispoli; Sabina Ferroni; Cesare Celeste Berra
Journal:  Cell Mol Life Sci       Date:  2022-05-03       Impact factor: 9.207

3.  Metabolite Signature of Albuminuria Involves Amino Acid Pathways in 8661 Finnish Men Without Diabetes.

Authors:  Lilian Fernandes Silva; Jagadish Vangipurapu; Ulf Smith; Markku Laakso
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

4.  Additive interaction between potentially modifiable risk factors and ethnicity among individuals in the Han, Tujia and Miao populations with first-ever ischaemic stroke.

Authors:  Na Zhang; Xinrui Wu; Mengyuan Tian; Xiaolei Wang; Jian Ding; Yong Tian; Chengcai Liang; Zhi Zeng; Hua Xiang; Hongzhuan Tan
Journal:  BMC Public Health       Date:  2021-06-03       Impact factor: 3.295

5.  Multi-Omics Analysis of Diabetic Nephropathy Reveals Potential New Mechanisms and Drug Targets.

Authors:  Qian Sha; Jinxiu Lyu; Meng Zhao; Haijuan Li; Mengzhe Guo; Qiang Sun
Journal:  Front Genet       Date:  2020-12-11       Impact factor: 4.599

6.  Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathy.

Authors:  Qiong Ma; Ligong Bian; Xi Zhao; Xuexia Tian; Hang Yin; Yutian Wang; Anhua Shi; Junzi Wu
Journal:  Mater Today Bio       Date:  2021-12-03

Review 7.  Obesity and CKD in Sub-Saharan Africa: A Narrative Review.

Authors:  Rotimi Oluyombo; Hameed Banjo Oguntade; Michael Soje; Omotola Obajolowo; Mahzuz Karim
Journal:  Kidney Med       Date:  2021-12-22

8.  Significance of Soluble CD93 in Type 2 Diabetes as a Biomarker for Diabetic Nephropathy: Integrated Results from Human and Rodent Studies.

Authors:  Minyoung Lee; Ho Seon Park; Min Yeong Choi; Hak Zoo Kim; Sung Jin Moon; Ji Yoon Ha; ARim Choi; Young Woo Park; Jong Suk Park; Eui-Cheol Shin; Chul Woo Ahn; Shinae Kang
Journal:  J Clin Med       Date:  2020-05-08       Impact factor: 4.241

9.  Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus.

Authors:  Mengni Li; Rongping Fan; Xuemin Peng; Jiaojiao Huang; Huajie Zou; Xuefeng Yu; Yan Yang; Xiaoli Shi; DeLin Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-15       Impact factor: 5.555

Review 10.  Diabetic patients with chronic kidney disease: Non-invasive assessment of cardiovascular risk.

Authors:  Nejc Piko; Sebastjan Bevc; Robert Ekart; Tadej Petreski; Nina Vodošek Hojs; Radovan Hojs
Journal:  World J Diabetes       Date:  2021-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.